Jeremy Schafer, PharmD, MBA

Alternative management approaches, including clinical pathways, should be considered to allow payers to facilitate transitions of care while practicing antimicrobial stewardship.
Authors explore the use of prostate-specific antigen screening and urge stakeholders to clarify how screening can be more usefully applied for prostate cancer.